This page contains exclusive content for the member of the following sections: TTS, IPITA. Log in to view.
Presenter: J. , Lakey1, ,
Authors: J. Lakey1, M Lamb1, A Breite2, D Chapman1, K Laugenour1, O Liang1, S Li1, R McCarthy2
P-197
Comparison of enzyme efficiency in porcine islet isolation and maturation from young pigs
J. Lakey1, M Lamb1, A Breite2, D Chapman1, K Laugenour1, O Liang1, S Li1, R McCarthy2
1 University of California Irvine Medical Center, Surgery, Orange, USA; 2 VitaCyte LLC, Indianapolis, USA
Objective: Islet xenotransplantation continues to be a potential option for treating patients with Type 1 diabetes. Recent FDA industry guidelines encourage tight control of the reagents and methods used in the islet manufacturing process. The aim of this study was to compare islet isolation and maturation of isolated porcine islets using either crude collagenase or a purified collagenase-protease mixture. The enzyme dosages were matched using values provided on the Certificates of Analysis.
Methods: Twelve porcine islet isolations were performed using pancreases recovered from young Yorkshire pigs (6-8 kg). Tissue was enzymatically digested with purified VitaCyte enzyme consisting of CIzyme Collagenase HA and BP Protease (Group 1) or Sigma Type V collagenase (Group 2). The islets were then cultured for 10 days at 37ºC. Isolated islets were assessed for yield, islet equivalents (IE), cell viability using FDA/PI, and function using a glucose stimulated insulin release (GSIR) assay and calculation of stimulation index (SI, ratio of insulin produced in high (28mM) over low glucose (2.8mM)).
Results: Results from these isolations are presented below with the results presented at mean ± standard error of the mean (SEM). No significant difference in results between groups.
Conclusions: These studies exhibit that a stable well-defined enzyme product can effectively isolate viable porcine islets, which can be used in clinical islet transplant. Moreover, since the enzyme activity of the purified material is defined, further modifications to the composition can be made to assess the tolerance of islet yield and function to variation in enzyme composition.
/P-197
Comparison of enzyme efficiency in porcine islet isolation and maturation from young pigs
J. Lakey1, M Lamb1, A Breite2, D Chapman1, K Laugenour1, O Liang1, S Li1, R McCarthy2
1 University of California Irvine Medical Center, Surgery, Orange, USA; 2 VitaCyte LLC, Indianapolis, USA
Objective: Islet xenotransplantation continues to be a potential option for treating patients with Type 1 diabetes. Recent FDA industry guidelines encourage tight control of the reagents and methods used in the islet manufacturing process. The aim of this study was to compare islet isolation and maturation of isolated porcine islets using either crude collagenase or a purified collagenase-protease mixture. The enzyme dosages were matched using values provided on the Certificates of Analysis.
Methods: Twelve porcine islet isolations were performed using pancreases recovered from young Yorkshire pigs (6-8 kg). Tissue was enzymatically digested with purified VitaCyte enzyme consisting of CIzyme Collagenase HA and BP Protease (Group 1) or Sigma Type V collagenase (Group 2). The islets were then cultured for 10 days at 37ºC. Isolated islets were assessed for yield, islet equivalents (IE), cell viability using FDA/PI, and function using a glucose stimulated insulin release (GSIR) assay and calculation of stimulation index (SI, ratio of insulin produced in high (28mM) over low glucose (2.8mM)).
Results: Results from these isolations are presented below with the results presented at mean ± standard error of the mean (SEM). No significant difference in results between groups.
Conclusions: These studies exhibit that a stable well-defined enzyme product can effectively isolate viable porcine islets, which can be used in clinical islet transplant. Moreover, since the enzyme activity of the purified material is defined, further modifications to the composition can be made to assess the tolerance of islet yield and function to variation in enzyme composition.
By viewing the material on this site you understand and accept that:
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada